Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Leukemia |
Free Subscription
1 Acta Haematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
Outcome and prognostic factors of haploidentical allogeneic hematopoietic stem
cell transplantation in pediatric relapsed or refractory ETV6/RUNX1-positive
acute lymphoblastic leukemia.
Acta Haematol. 2024 Jan 20. doi: 10.1159/000536396.
PubMed
Abstract available
Second Hematologic Malignancies Associated With Primary Mediastinal Germ Cell
Tumors: A Population-based Study.
Am J Clin Oncol. 2024;47:58-63.
PubMed
Abstract available
Additional booster doses in patients with chronic lymphocytic leukemia induce
humoral and cellular immune responses to SARS-CoV-2 similar to natural infection
regardless ongoing treatments: A study by ERIC, the European Research Initiative
on CLL.
Am J Hematol. 2024 Jan 24. doi: 10.1002/ajh.27218.
PubMed
Abstract available
Phase 2 study of epigenetic priming with decitabine followed by cytarabine for
acute myeloid leukemia in older patients.
Am J Hematol. 2024 Jan 22. doi: 10.1002/ajh.27212.
PubMed
Abstract available
Comparison of fludarabine-based conditioning regimens in adult cord blood
transplantation for myeloid malignancy: A retrospective, registry-based study.
Am J Hematol. 2024;99:236-244.
PubMed
Abstract available
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics
of a nationwide VEXAS cohort.
Am J Hematol. 2024;99:254-262.
PubMed
Abstract available
Toward an improved understanding of hypomethylating agent and venetoclax
therapies.
Am J Hematol. 2024;99:152-154.
PubMed
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3
antibody, in combination with decitabine or azacitidine in high- or very
high-risk myelodysplastic syndromes.
Am J Hematol. 2024;99:E32-E36.
PubMed
Abstract available
Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia:
a French multicentric retrospective study.
Ann Hematol. 2024 Jan 26. doi: 10.1007/s00277-024-05623.
PubMed
Abstract available
Relapse and transformation to myelodysplastic syndrome and acute myeloid leukemia
following immunosuppressive therapy for aplastic anemia is more common as
compared to allogeneic stem cell transplantation with a negative impact on
survival.
Ann Hematol. 2024 Jan 20. doi: 10.1007/s00277-024-05621.
PubMed
Abstract available
BRCA2 germline mutation in familial leukaemia with familial breast cancer: a case
report.
Ann Hematol. 2024;103:685-687.
PubMed
In-depth molecular analysis of lymphomas with lymphoplasmacytic differentiation
may provide more precise diagnosis and rational treatment allocation.
Ann Hematol. 2024;103:553-563.
PubMed
Abstract available
Feasibility of allogeneic hematopoietic stem cell transplantation in advanced
age.
Ann Hematol. 2024;103:583-591.
PubMed
Abstract available
Darwin, MSI2, and relapse in T-ALL.
Blood. 2024;143:294-296.
PubMed
Anticancer drug exposure in utero and leukemia.
Blood. 2024;143:293-294.
PubMed
PI3Kgamma maintains the self-renewal of acute myeloid leukemia stem cells by
regulating the pentose phosphate pathway.
Blood. 2024 Jan 25:blood.2023022202. doi: 10.1182/blood.2023022202.
PubMed
Abstract available
MRD in AML: who, what, when, where, and how?
Blood. 2024;143:296-298.
PubMed
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving
venetoclax-based nonintensive therapy.
Blood. 2024;143:336-341.
PubMed
Abstract available
TIM-3/Galectin-9 interaction and glutamine metabolism in AML cell lines, HL-60
and THP-1.
BMC Cancer. 2024;24:125.
PubMed
Abstract available
Development of a risk assessment model for cardiac injury in patients newly
diagnosed with acute myeloid leukemia based on a multicenter, real-world analysis
in China.
BMC Cancer. 2024;24:132.
PubMed
Abstract available
A prognostic score system in adult T-cell acute lymphoblastic leukemia after
hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2024 Jan 24. doi: 10.1038/s41409-024-02211.
PubMed
Abstract available
Selective histone deacetylase inhibitor after allo-HCT for T-cell acute
lymphoblastic leukemia or T-cell lymphoma.
Bone Marrow Transplant. 2024 Jan 23. doi: 10.1038/s41409-023-02191.
PubMed
Manufacturing of primary CAR-NK cells in an automated system for the treatment of
acute myeloid leukemia.
Bone Marrow Transplant. 2024 Jan 22. doi: 10.1038/s41409-023-02180.
PubMed
Abstract available
The presenting symptom signatures of incident cancer: evidence from the English
2018 National Cancer Diagnosis Audit.
Br J Cancer. 2024;130:297-307.
PubMed
Abstract available
Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia.
Br J Cancer. 2024;130:317-326.
PubMed
Abstract available
Survival difference between secondary and de novo acute myeloid leukemia by age,
antecedent cancer types, and chemotherapy receipt.
Cancer. 2024 Jan 20. doi: 10.1002/cncr.35214.
PubMed
Abstract available
Iron overload promotes the progression of MLL-AF9 induced acute myeloid leukemia
by upregulation of FOS.
Cancer Lett. 2024 Jan 17:216652. doi: 10.1016/j.canlet.2024.216652.
PubMed
Abstract available
The imipridone ONC213 targets alpha-ketoglutarate dehydrogenase to induce
mitochondrial stress and suppress oxidative phosphorylation in acute myeloid
leukemia.
Cancer Res. 2024 Jan 24. doi: 10.1158/0008-5472.CAN-23-2659.
PubMed
Abstract available
Pretransplant hepatomegaly is linked to relapse in patients with leukemia and
myelodysplastic syndrome not in remission.
Int J Hematol. 2024 Jan 22. doi: 10.1007/s12185-023-03707.
PubMed
Abstract available
TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed
childhood acute lymphoblastic leukemia.
Int J Hematol. 2024 Jan 25. doi: 10.1007/s12185-024-03710.
PubMed
Abstract available
Raccoon Eyes Presentation in a Child Diagnosed With Acute Lymphoblastic Leukemia:
A Case Report.
J Pediatr Hematol Oncol. 2024 Jan 29. doi: 10.1097/MPH.0000000000002813.
PubMed
Abstract available
Therapy with mosunetuzumab, a bispecific antibody for relapsed/refractory hairy
cell leukemia.
Leuk Lymphoma. 2024 Jan 22:1-4. doi: 10.1080/10428194.2024.2304026.
PubMed
Prevalence of primary chronic lymphocytic leukemia in the United States: a
cross-sectional study using the SEER database.
Leuk Lymphoma. 2024 Jan 22:1-2. doi: 10.1080/10428194.2023.2300714.
PubMed
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the
EPICOVIDEHA survey.
Leuk Lymphoma. 2024;65:199-208.
PubMed
Abstract available
Comprehensive genomic profiling reveals molecular subsets of ASXL1-mutated
myeloid neoplasms.
Leuk Lymphoma. 2024;65:209-218.
PubMed
Abstract available
RAISING revealed a heterogenous pattern of HTLV-1 clonality after
HLA-haploidentical peripheral blood stem cell transplantation for ATL.
Leuk Lymphoma. 2023 Nov 1:1-4. doi: 10.1080/10428194.2023.2276058.
PubMed
Correction to: TAL1 hijacks MYCN enhancer that induces MYCN expression and
dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia.
Leukemia. 2024 Jan 25. doi: 10.1038/s41375-023-02125.
PubMed
Impact of hemodilution on flow cytometry based measurable residual disease
assessment in acute myeloid leukemia.
Leukemia. 2024 Jan 25. doi: 10.1038/s41375-024-02158.
PubMed
Abstract available
Clinical evaluation of complete remission (CR) with partial hematologic recovery
(CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts.
Leukemia. 2024 Jan 23. doi: 10.1038/s41375-024-02143.
PubMed
Thank you for your interest in scientific medicine.